Zhejiang Orient Gene Biotech Co Ltd (688298) - Total Liabilities

Latest as of September 2025: CN¥1.01 Billion CNY ≈ $148.51 Million USD

Based on the latest financial reports, Zhejiang Orient Gene Biotech Co Ltd (688298) has total liabilities worth CN¥1.01 Billion CNY (≈ $148.51 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Zhejiang Orient Gene Biotech Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Zhejiang Orient Gene Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Zhejiang Orient Gene Biotech Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Zhejiang Orient Gene Biotech Co Ltd Competitors by Total Liabilities

The table below lists competitors of Zhejiang Orient Gene Biotech Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
FinVolution Group F:PP3	Germany	€8.57 Billion
Hangzhou Dadi Haiyang Environmental Protection Co. Ltd. SHE:301068	China	CN¥496.16 Million
China Railway Harbin Group of Technology Corp. A SHG:688459	China	CN¥643.36 Million
Pareto Bank ASA OL:PARB	Norway	Nkr18.87 Billion
Canadian Banc Corp TO:BK	Canada	CA$385.42 Million
Northfield Bancorp Inc NASDAQ:NFBK	USA	$5.06 Billion
Beijing StarNeto Technology Co Ltd SHE:002829	China	CN¥573.58 Million
Indointernet Tbk PT JK:EDGE	Indonesia	Rp2.14 Trillion

Liability Composition Analysis (2016–2024)

This chart breaks down Zhejiang Orient Gene Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688298 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.28	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.16	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.14	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhejiang Orient Gene Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhejiang Orient Gene Biotech Co Ltd (2016–2024)

The table below shows the annual total liabilities of Zhejiang Orient Gene Biotech Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥1.30 Billion ≈ $190.69 Million	-9.89%
2023-12-31	CN¥1.45 Billion ≈ $211.63 Million	-39.25%
2022-12-31	CN¥2.38 Billion ≈ $348.38 Million	+14.01%
2021-12-31	CN¥2.09 Billion ≈ $305.57 Million	+86.14%
2020-12-31	CN¥1.12 Billion ≈ $164.16 Million	+944.66%
2019-12-31	CN¥107.38 Million ≈ $15.71 Million	-17.15%
2018-12-31	CN¥129.62 Million ≈ $18.97 Million	+6.94%
2017-12-31	CN¥121.20 Million ≈ $17.74 Million	-14.82%
2016-12-31	CN¥142.28 Million ≈ $20.82 Million	--

About Zhejiang Orient Gene Biotech Co Ltd

SHG:688298 China Medical Devices

Market Cap

$567.59 Million

CN¥3.88 Billion CNY

Market Cap Rank

#11725 Global

#3385 in China

Share Price

CN¥19.24

Change (1 day)

-1.74%

52-Week Range

CN¥19.24 - CN¥29.94

All Time High

CN¥221.47